Molecule Structure

Scientific Name

Maribavir

Description of the Drug

Maribavir is a cytomegalovirus (CMV) pUL97 kinase inhibitor used for the treatment of refractory post-transplant CMV infection.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06234

Brand Name(s)

Livtencity

Company Owner(s)

Takeda Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Phosphotransferase pUL97 SINGLE PROTEIN INHIBITOR CHEMBL1287608
Serine/threonine-protein kinase BGLF4 SINGLE PROTEIN INHIBITOR CHEMBL3833483

Unichem Links

SureChEMBL SCHEMBL791309
DrugBank DB06234
PubChem: Thomson Pharma 14804326 14853350
PubChem 471161
LINCS LSM-45590
Nikkaji J1.159.817J
EPA CompTox Dashboard DTXSID60170091
ChemicalBook CB6375292
PubChem: Drugs of the Future 12015036
ZINC ZINC000003824412